Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT06414551 Not yet recruiting - Clinical trials for Chronic Total Occlusion of Coronary Artery

Calcification on CTCA of a CTO and PCI Outcomes

Start date: July 1, 2024
Phase:
Study type: Observational

A chronic total occlusion (CTO) is present in 15-20% of patients who are referred for invasive coronary angiography. CTO Percutaneous Coronary Intervention (PCI) procedure success rates have increased over the years and can be as high as 90% when performed by high-volume CTO operators.Procedurally, excess calcification in the CTO anatomy is one factor which makes it difficult to complete the procedure or obtain ideal stent expansion. Excess calcification is best identified by Computed Tomography Coronary Angiography (CTCA) rather than invasive angiography. The investigators plan to retrospectively evaluate CTCA in patients who underwent CTO PCI and correlate calcification characteristics with CTO PCI outcomes and tools utilised for calcium modification.

NCT ID: NCT06414460 Not yet recruiting - Clinical trials for Locally Advanced/Metastatic Solid Tumors

Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors

Start date: March 1, 2025
Phase: Phase 1
Study type: Interventional

The study has consists of two parts, a dose escalation part (Part 1) and a dose selection optimization part (Part 2). The primary objectives of this study are to evaluate the safety and tolerability of ISM3412 in participants with locally advanced/metastatic solid tumors, and to determine the RP2D of ISM3412.

NCT ID: NCT06414408 Not yet recruiting - Clinical trials for Sexually Transmitted Diseases, Bacterial

Randomized Directly Observed Therapy Study to Interpret Clinical Trials of Doxy-PEP

DOT-Doxy-PEP
Start date: September 1, 2024
Phase: Early Phase 1
Study type: Interventional

Rates of bacterial sexually transmitted infections (STIs) are rising globally, demanding innovative interventions beyond the scope of current efforts to prevent STIs. The United States Doxycycline Post-exposure Prophylaxis (DoxyPEP) Study has demonstrated the efficacy of doxycycline post-exposure prophylaxis (PEP) among men who have sex with men and transgender women; but puzzlingly, doxycycline PEP was found ineffective in cisgender women in the Kenyan doxycycline Post-Exposure Prophylaxis (dPEP) study, with preliminary data suggesting the low medication adherence may explain the null result. By study end, the investigators will have developed adherence measurement methods for doxycycline in hair, blood, and urine, and will use these techniques to help interpret the Kenyan dPEP study, and to examine the relative performance of these methods within the United States DoxyPEP trial, establishing adherence metrics for current and future rollout studies of doxycycline post-exposure prophylaxis

NCT ID: NCT06414148 Not yet recruiting - Clinical trials for Relapsed/Refractory Large B-cell Lymphoma

MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma

EpLCART
Start date: May 7, 2024
Phase: Phase 2
Study type: Interventional

This is a Phase II open-label, two-arm randomised non-comparative, multi-centre study to evaluate the efficacy of Epcor-only (Epcoritamab alone) or Epcor-R2 (Epcoritamab, lenalidomide and rituximab) as consolidation post anti-CD19 CAR T-cell therapy for patients that have responded by conventional criteria but who are at high risk of progression by virtue of being Minimal Residual Disease (MRD) positive as determined by a Circulating Tumour DNA (ctDNA) assay.

NCT ID: NCT06414005 Recruiting - Clinical trials for Partial Thickness Rotator Cuff Tear

A Phase 2b/3 Study of TPX-115 on Partial-thickness Rotator Cuff Tear

Start date: April 15, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

Rotator cuff tear is one of the most common shoulder diseases and conservative treatment is commonly used for tears involving ≤50% of tendon thickness. Since conventional conservative treatments are not fundamental to repair tendon tissue, there is a growing need of new therapy to improve structural outcome. This study assesses the safety and efficacy of allogeneic fibroblasts on partial-thickness rotator cuff tear. The primary outcome is change in Constant Score (CS) at 24 weeks after TPX-115 injection. Secondary outcomes include changes from baseline in CS, Visual Analogue Score (VAS) pain score, American Shoulder and Elbow Surgeons (ASES) score, Quick Disabilities of the Arm, Shoulder and Hand (Quick-DASH), Simple Shoulder Test (SST), and functional evaluations including Range of Motion (ROM) at 4, 12, 24 and 52 weeks after administration and structural evaluation using MRI at 24 and 52 weeks after injection.

NCT ID: NCT06413654 Not yet recruiting - Clinical trials for Neuromyelitis Optica Spectrum Disorders

A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)

Start date: June 20, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

To evaluate the efficacy and safety of B001 injection in aquaporin-4 antibody positive patients with neuromyelitis optica spectrum disorder.

NCT ID: NCT06413641 Recruiting - Clinical trials for Coronary Artery Disease

VIsualization of Coronary Artery Disease for Modification of RISK Factors

VICAD-RISK
Start date: March 12, 2024
Phase: N/A
Study type: Interventional

The VICAD-RISK study assesses if visualization of coronary CT angiography images in participants with non-obstructive coronary artery disease will improve LDL lowering, reduce reporting of side effects by cholesterol lowering medications, and modify the coronary artery disease phenotype over 12 months.

NCT ID: NCT06413602 Not yet recruiting - Multiple Sclerosis Clinical Trials

The Synergistic Effects of AIH and FES in Persons With MS

Start date: August 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to examine how neuromuscular electrical stimulation (NMES), may synergistically enhance corticospinal excitability in people with relapsing form multiple sclerosis (MS). This is an important intermediate step to evaluate the potential of AIH + NMES as a plasticity-priming strategy for more efficacious interventions for persons with MS. This study will measure ankle torque generation and amplitude of motor evoked potentials (MEPs) using a repeated measures study design in order to better understand the effects of AIH combined with NMES, as compared to only receiving NMES, and only receiving AIH.

NCT ID: NCT06413524 Not yet recruiting - COPD Clinical Trials

The Effects of Different Vibration Exercises on COPD Patients

Start date: May 21, 2024
Phase: N/A
Study type: Interventional

Pulmonary rehabilitation is effective in improving exercise tolerance, dyspnea, and fatigue in patients with COPD, and exercise training is an important component of pulmonary rehabilitation. Vibration training can be used as a supplement or alternative to traditional exercise and is a short, safe rehabilitation training. COPD patients will be recruited and randomly assigned to the control group, whole-body vibration training group, or local vibration training group. The study aims to confirm the rehabilitative benefits of enhancing lower limb muscle strength, exercise endurance, and the quality of life related to COPD in patients.

NCT ID: NCT06413472 Active, not recruiting - Clinical trials for Acute Respiratory Distress Syndrome

Comparing Formulations of Mechanical Power Using Geometric Methods

Start date: January 1, 2024
Phase:
Study type: Observational

We aimed to compare different formulations of mechanical power using geometric methods at varying inspiratory rise and pause times.